Form D · Other
Hekate Health Sciences Inc.
Vancouver, A1 · CIK 0001949705
Offering snapshot reported Oct 5, 2022 · SEC filing
- Reported sold
- $330K Offering amount: $330K
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 6, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 5, 2022 | Initial | $330,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-460838
Common shares at a price of USD$0.135 per share
Source: Form D, filed Oct 5, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Justin Kates | Director |
| Vasek Pospisil, | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
142 757 West Hastings Street Mailbox 688
Vancouver, A1, V6C 1A1
Vancouver, A1, V6C 1A1